Bruce N. Jacobs sold $8.9M of KYMR stock

Bruce N. Jacobs, Chief Financial Officer of Kymera Therapeutics, Inc. (KYMR), sold 77,109 shares of KYMR stock worth $8.9M, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 30, 2026, 2 days before it was made public.

KYMR has moved +11.2% since the trade date, from $114.67 to $127.57 (Nov 13, 2026 close).